What are my alternatives to knee replacement?
Compare nonsurgical knee arthritis care, injection choices, and selected surgical alternatives—with evidence, limits, and questions for your clinician.
Read the guide ↗Medically reviewed by Charles A. DeCook, MD ·
← All optionsLearn about the evidence
Opioids as an arthritis path
Medicare may pay. That does not make this good care.
Who might it suit?
For: Discussing an existing prescription safely with your clinician.
Not for: A routine knee or hip OA treatment path here.
Limits and important cautions
This is not a recommendation to abruptly stop medication. Chronic OA management differs from brief, supervised postoperative pain treatment.
What happens, how long, and what could it cost?
- What happens
- Review medicines, health conditions, contraindications, and the exact dose with your clinician or pharmacist.
- When might I notice a change?
- Timing depends on the medicine and formulation; follow its label and prescribed plan.
- How long might benefit last?
- Symptom control varies. Ask how long to try it before reviewing the result.
- Repeat treatment
- Review ongoing need and adverse effects. Do not abruptly stop prescribed opioids.
- Activity and recovery
- Ask about driving, interactions, and activities affected by the specific medicine.
- Ask for a complete estimate
- Medicine, visits, and any necessary monitoring.
Use this as a consultation guide. A timeline is not a guarantee; the evidence and FDA sections below remain part of the decision.
THE EVIDENCE IN CONTEXT
Not a routine long-term OA pathway
Read the 2 selected references
- Krebs et al.: SPACE opioid versus nonopioid trial ↗
Compared medication strategies for chronic back or hip/knee OA pain over 12 months; not a study of short-term pain treatment after surgery.
- ACR/Arthritis Foundation: OA management ↗
2019 guideline, published in 2020. Recommendations vary by joint; it predates many newer trials.
FDA status
Approved drugs · label-specific useApproved pain medicines exist; approval is not a recommendation for routine OA treatment.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.What do professional guidelines say?
AAHKS: Avoid for hip or knee OA except exceptional cases when other care has failed and replacement is not possible. Use the lowest dose for the shortest time.
ACR: Against non-tramadol opioids; tramadol is only conditionally recommended.
Will Medicare cover it?
Prescription coverage may apply. Payment is not an evidence endorsement.